Sohn Catherine A. (CIK 1555132) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-08). Recent activity: Buy MAZE (2,493 shares), Sell MAZE (2,493 shares), Buy MAZE (20,744 shares), Buy MAZE (2,895 shares), Buy MAZE (3,281 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Buy | 2,493 | $25,977 |
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Sell | 2,493 | $96,280 |
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Buy | 20,744 | $216,152 |
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Buy | 2,895 | $30,166 |
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Buy | 3,281 | $34,188 |
| 2026-01-08 | Maze Therapeutics, Inc. (MAZE) | Director | Sell | 26,920 | $1.1M |
| 2026-01-05 | Altimmune, Inc. (ALT) | Director | Buy | 500 | $2,120 |
| 2025-03-18 | Altimmune, Inc. (ALT) | Director | Buy | 1,000 | $5,780 |
Source: SEC Form 4 filings · as of 2026-01-08